2242331
Cooperative Agreement
Overview
Grant Description
SBIR PHASE II: A NOVEL RESPIRATORY BAG-VALVE-MASK RESUSCITATOR -THE BROADER IMPACT/COMMERCIAL POTENTIAL OF THIS SMALL BUSINESS INNOVATION RESEARCH (SBIR) PHASE II PROJECT IS A NOVEL DEVICE WHICH REDUCES INJURY TO PATIENTS BY EMERGENCY PERSONNEL WHEN USING A BAG-VALVE-MASK (BVM) MANUAL RESUSCITATOR. BVMS ARE USED IN PRE-HOSPITAL AND HOSPITAL SETTINGS BY EMERGENCY MEDICAL PERSONNEL ON A DAILY BASIS TO DELIVER AIR TO CRITICALLY ILL PATIENTS. THEIR BASIC DESIGN HAS BEEN IN PLACE FOR OVER 60 YEARS AND ARE OFTEN MISUSED RESULTING IN DAMAGE, COMPLICATIONS, OR OCCASIONALLY FATAL LUNG INJURY. THIS PROJECT WILL COMPLETE DEVELOPMENT OF A NOVEL BVM THAT PRECISELY CONTROLS THE VOLUMES AND PRESSURES DELIVERED, AND AIMS TO REDEFINE THE STAGNANT BVM MARKET WHICH IS PROJECTED TO SURPASS $750M ANNUALLY BY 2025. THIS SMALL BUSINESS INNOVATION RESEARCH (SBIR) PHASE II PROJECT DEVELOPS A NOVEL, ADJUSTABLE, UNIVERSAL BAG-VALVE-MASK RESUSCITATOR ENABLING EMERGENCY PROVIDERS TO DELIVER AIR VOLUMES AND PRESSURES CUSTOMIZED TO PATIENT BODY SIZE. CURRENT DEVICES ARE COMMONLY MISUSED, EVEN BY HIGHLY TRAINED MEDICAL PERSONNEL, RESULTING IN HYPERVENTILATION, BAROTRAUMA, AND OCCASIONAL DEATH. THE PROJECT WILL COMPLETE REMAINING DESIGN AND TESTING TASKS, AND A HUMAN FACTORS PROOF OF CONCEPT STUDY TO DEMONSTRATE USERS ARE ABLE TO QUICKLY AND PROPERLY UTILIZE THE DEVICE WITH MINIMAL INSTRUCTION WILL BE PERFORMED. THE SECOND OBJECTIVE WILL ADDRESS MANUFACTURABILITY AND TESTING REQUIREMENTS WITHIN STANDARDS FOR US APPROVAL. FINALLY, THE THIRD OBJECTIVE IS TO ESTABLISH THE ASSEMBLY PROCESSES AND INITIAL QUALITY CONTROL TESTING TO ENSURE CONSISTENT MANUFACTURING AT SCALE AND IN A COST EFFECTIVE AND QUALITY CONSISTENT MANNER. THIS AWARD REFLECTS NSF'S STATUTORY MISSION AND HAS BEEN DEEMED WORTHY OF SUPPORT THROUGH EVALUATION USING THE FOUNDATION'S INTELLECTUAL MERIT AND BROADER IMPACTS REVIEW CRITERIA.- SUBAWARDS ARE NOT PLANNED FOR THIS AWARD.
Awardee
Funding Goals
THE GOAL OF THIS FUNDING OPPORTUNITY, "NSF SMALL BUSINESS INNOVATION RESEARCH PHASE II (SBIR)/ SMALL BUSINESS TECHNOLOGY TRANSFER (STTR) PROGRAMS PHASE II", IS IDENTIFIED IN THE LINK: HTTPS://WWW.NSF.GOV/PUBLICATIONS/PUB_SUMM.JSP?ODS_KEY=NSF22552
Grant Program (CFDA)
Awarding / Funding Agency
Place of Performance
Indianapolis,
Indiana
46259-8603
United States
Geographic Scope
Single Zip Code
Related Opportunity
22-552
Analysis Notes
Amendment Since initial award the total obligations have decreased 100% from $999,931 to $0.
Compact Medical was awarded
Cooperative Agreement 2242331
from National Science Foundation in November 2023 with work to be completed primarily in Indianapolis Indiana United States.
The grant
has a duration of 2 years and
was awarded through assistance program 47.084 NSF Technology, Innovation, and Partnerships.
SBIR Details
Research Type
SBIR Phase II
Title
SBIR Phase II: A Novel Respiratory Bag-Valve-Mask Resuscitator
Abstract
The broader impact/commercial potential of this Small Business Innovation Research (SBIR) Phase II project is a novel device which reduces injury to patients by emergency personnel when using a bag-valve-mask (BVM) manual resuscitator. BVMs are used in pre-hospital and hospital settings by emergency medical personnel on a daily basis to deliver air to critically ill patients. Their basic design has been in place for over 60 years and are often misused resulting in damage, complications, or occasionally fatal lung injury. This project will complete development of a novel BVM that precisely controls the volumes and pressures delivered, and aims to redefine the stagnant BVM market which is projected to surpass $750M annually by 2025.
This Small Business Innovation Research (SBIR) Phase II project develops a novel, adjustable, universal bag-valve-mask resuscitator enabling emergency providers to deliver air volumes and pressures customized to patient body size. Current devices are commonly misused, even by highly trained medical personnel, resulting in hyperventilation, barotrauma, and occasional death. The project will complete remaining design and testing tasks, and a human factors proof of concept study to demonstrate users are able to quickly and properly utilize the device with minimal instruction will be performed. The second objective will address manufacturability and testing requirements within standards for US approval. Finally, the third objective is to establish the assembly processes and initial quality control testing to ensure consistent manufacturing at scale and in a cost effective and quality consistent manner.
This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
Topic Code
MD
Solicitation Number
NSF 22-552
Status
(Complete)
Last Modified 11/6/23
Period of Performance
11/1/23
Start Date
10/31/25
End Date
Funding Split
$0.0
Federal Obligation
$0.0
Non-Federal Obligation
$0.0
Total Obligated
Additional Detail
Award ID FAIN
2242331
SAI Number
None
Award ID URI
SAI EXEMPT
Awardee Classifications
Small Business
Awarding Office
491503 TRANSLATIONAL IMPACTS
Funding Office
491503 TRANSLATIONAL IMPACTS
Awardee UEI
ELXDAGG2NEX4
Awardee CAGE
8FAY6
Performance District
IN-06
Senators
Todd Young
Mike Braun
Mike Braun
Modified: 11/6/23